Last Updated on: 26th July 2024, 01:23 pm
Mr. Colwyn Headley, Ph.D. from Stanford University, is now a member of Wonderfeel’s Scientific Advisory Board, and Mr. Luis Cifuentes, MD, a clinical pharmacologist, has been elevated to the role of Director of Research and Development.
Wonderfeel Biosciences, a frontrunner in longevity technologies, has announced noteworthy enhancements to its scientific team, marking a pivotal advancement in its mission to tackle age-related decline through innovative nutraceutical and pharmaceutical solutions.
Dr. Colwyn “CoCo” Headley has joined Wonderfeel’s Scientific Advisory Board. A distinguished Postdoctoral Fellow at Stanford University, Dr. Headley is celebrated for his research on mitochondrial dysfunction associated with aging and its impact on immunity. His recently published paper, ‘Mitochondrial Replacement Therapy to Treat Aging-associated Immune Dysregulations,’ has been recognised as one of the most groundbreaking contributions to the field.
Baran Dilaver, CEO of Wonderfeel, emphasised the importance of Dr. Headley’s work, stating, “Coco is one of the most exciting young scientific minds of his generation. His novel research takes an out-of-the-box approach and, through subsequent inventions, is poised to impact billions of people worldwide. We are eager to collaborate with him and leverage his deep expertise in mitochondrial health.”
Dr. Headley expressed his enthusiasm, remarking, “Preserving cellular health is integral to health aging. Helping the Wonderfeel team in unraveling the mechanisms of action of their unique blend of compounds and understanding how they improve cellular health, particularly mitochondrial health, aligns perfectly with my long-standing research interests.”
In other news from Wonderfeel, Dr. Luis Cifuentes has been elevated to the position of Director of R&D and Product Development. Dr. Cifuentes is a professor, medical doctor, and clinical pharmacologist, holding advanced degrees from the University of London, UK, and McGill University in Canada. With a career spanning 25 years across the pharmaceutical, biotechnology, and medical device sectors, he joined Wonderfeel full-time in December 2023, assisting Chief Medical Officer Dr. Andrew Salzman in drug discovery and product development while leading the company’s preclinical trials. “Dr. Cifuentes brings incredible depth and value to our efforts, and his dedication to our cause and to the scientific method made him quickly a pillar of our RD efforts,” noted Patricia Ryan, co-founder of Wonderfeel.
Dr. Cifuentes remarked, “Joining the Wonderfeel team has been a fascinating experience, as the company’s advancements are highly focused on preventing various systemic alterations, thereby enhancing overall well-being and increasing life expectancy for humanity.”
